GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 227 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $220,000 | -12.0% | 6,219 | +0.5% | 0.00% | 0.0% |
Q1 2021 | $250,000 | +5.5% | 6,191 | +11.8% | 0.00% | 0.0% |
Q4 2020 | $237,000 | -34.3% | 5,540 | +22.5% | 0.00% | -50.0% |
Q4 2019 | $361,000 | -51.9% | 4,523 | -77.8% | 0.00% | -71.4% |
Q1 2017 | $750,000 | +152.5% | 20,390 | -0.5% | 0.01% | +133.3% |
Q4 2016 | $297,000 | – | 20,490 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Logos Global Management LP | 850,000 | $46,869,000 | 6.00% |
Asymmetry Capital Management, L.P. | 155,232 | $8,559,000 | 5.50% |
Grace Capital | 124,749 | $6,878,000 | 5.33% |
Fernwood Investment Management, LLC | 187,477 | $10,337,000 | 4.88% |
Perceptive Advisors | 5,800,996 | $319,867,000 | 4.67% |
ArchPoint Investors | 217,510 | $11,993,000 | 3.83% |
GREAT POINT PARTNERS LLC | 655,676 | $36,154,000 | 3.25% |
Profit Investment Management, LLC | 42,196 | $2,328,000 | 1.44% |
Bain Capital Public Equity Management II, LLC | 381,868 | $21,056,000 | 1.39% |
Taylor Wealth Management Partners | 52,597 | $2,900,000 | 1.33% |